InMode to Present at the UBS Global Healthcare Virtual Conference
InMode Ltd. (Nasdaq: INMD) will participate in a fireside chat at the UBS Global Healthcare Virtual Conference on May 26 at 10:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode Ltd. (Nasdaq: INMD) will participate in a fireside chat at the UBS Global Healthcare Virtual Conference on May 26 at 10:00 a.m. ET. Key executives, including CEO Moshe Mizrahy and CFO Yair Malca, will engage in discussions and be available for one-on-one meetings. The live webcast can be accessed on InMode's investor relations site, with an archive available for 30 days post-event. InMode specializes in innovative medical technologies utilizing RF technology across various medical fields.
Details
News Market Reaction – INMD
The recorded move for INMD in the trading session of this news was -2.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM, Israel, May 13, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate in a fireside chat at the UBS Global Healthcare Virtual Conference on Wednesday, May 26. Matthew Taylor, CFA, Managing Director, U.S. Medical Supplies & Devices Analyst will lead the discussion at 10:00a.m. ET.
Members of InMode's management team including Moshe Mizrahy, Chairman and Chief Executive Officer, Yair Malca, Chief Financial Officer, Dr. Spero Theodorou, M.D., Chief Medical Officer, and Shakil Lakhani, President of North America, will participate in the fireside chat and will be available for one-on-one virtual meetings during the conference. To schedule a meeting, please contact your UBS salesperson. A live webcast of the presentation will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 30 days following the live presentation.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel RF technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654
View original content:http://www.prnewswire.com/news-releases/inmode-to-present-at-the-ubs-global-healthcare-virtual-conference-301290129.html
SOURCE InMode Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.